Table 1.
Demographic and clinical characteristics of the study cohort (N = 195)
| Age (y) | 66 ± 12 |
| Male | 100 (51) |
| Black | 41 (22) |
| Comorbid conditions | |
| Hypertension | 143 (73) |
| Hyperlipidemia | 140 (72) |
| Diabetes mellitus | 59 (30) |
| Coronary heart disease | 43 (22) |
| Heart failure | 7 (4) |
| Chronic kidney disease | 50 (27) |
| Previous stroke/TIA | 54 (28) |
| CHA2DS2-VASc score | 4.6 ± 1.5 |
| Left atrial size on echocardiography | |
| Normal | 127 (68) |
| Mildly dilated | 38 (20) |
| Moderately dilated | 11 (6) |
| Severely dilated | 10 (5) |
| Medications | |
| Aspirin | 105 (54) |
| Clopidogrel | 14 (7) |
| Aspirin + clopidogrel | 58 (30) |
| Aspirin + dipyridamole | 2 (1) |
| Anticoagulants before ILR | 22 (12) |
Values are given as mean ± SD or n (%).
ILR = implantable loop recorder; TIA = transient ischemic attack.